InvestorsHub Logo
Followers 33
Posts 2835
Boards Moderated 2
Alias Born 10/24/2015

Re: None

Friday, 04/29/2022 7:22:52 PM

Friday, April 29, 2022 7:22:52 PM

Post# of 42
ASGCT title:

Enabling the Engineering of iPSC Based Cell Therapies Using MAD7, a Novel CRISPR Nuclease.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPSC News